NCT06035952

Brief Summary

The investigators aim to validate three-dimensional topographical scanning technology as a tool for evaluation of scoliosis. Through the incorporation of 3D topographical technology in the measurement of deformity, the investigators hope to validate a novel approach to quantify deformity progression and provide an accessible alternative to traditional radiographic workup.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 7, 2023

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

August 31, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2023

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

August 31, 2023

Last Update Submit

September 6, 2023

Conditions

Keywords

scoliosistopographical scanning

Outcome Measures

Primary Outcomes (1)

  • Accuracy of scanning device to predict clinically significant Cobb Angle

    The primary study endpoint, or primary outcome, is whether the 3D scan's predicted probability of clinically significant Cobb angle correlates with the ground truth radiograph obtained Cobb angle at the defined rate. The percentage (%) of patient scans with predicted probabilities that correlate with ground truth results will be reported.

    Through study completion, an average of 3 months

Secondary Outcomes (1)

  • Repeatability of 3D scan analysis

    Within 48 hours

Study Arms (1)

Intervention

This study will have one cohort. This group of patients will undergo 3D scanning with a smartphone, and will also have standard of care diagnostics, such as an X-ray.

Diagnostic Test: 3D topographical scan

Interventions

3D topographical scanDIAGNOSTIC_TEST

Subjects will undergo a quick, radiation-free, no contact 3D scan using a smartphone.

Intervention

Eligibility Criteria

Age10 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will include children and adolescent patients 10 to 18 years old who present to a pediatric orthopedic clinic for scoliosis evaluation. This age range was chosen as it is the age range in which Adolescent Idiopathic Scoliosis commonly appears, and the device is intended for screening for this condition.

You may qualify if:

  • Ages 10 and 18 years old

You may not qualify if:

  • Scoliosis caused by another condition (e.g., secondary scoliosis)
  • Parents/guardians unable to consent
  • English is not the primary language (to avoid miscommunication)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Stanford University School of Medicine

Palo Alto, California, 94063, United States

RECRUITING

Duke University

Durham, North Carolina, 27708, United States

RECRUITING

MeSH Terms

Conditions

Scoliosis

Condition Hierarchy (Ancestors)

Spinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Kali Tileston, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael J. Gardner, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2023

First Posted

September 13, 2023

Study Start

August 7, 2023

Primary Completion

October 15, 2023

Study Completion

December 15, 2023

Last Updated

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations